Guojin Securities released a research report on April 22 stating that it gave Kangenbei (600572.SH) an increase in its holdings. The main reasons for the rating include: 1) product structure optimization, healthy growth in the core business of Traditional Chinese Medicine Health; 2) remarkable brand building results, continued expansion of large brands and large varieties; 3) focusing on the main business and continuing to promote resource integration. (Mainichi Keizai Shimbun)
国金证券4月22日发布研报称，给予康恩贝（600572.SH）增持评级。评级理由主要包括：1）产品结构优化，中药大健康核心业务良性增长；2）品牌建设成效显著，大品牌大品种继续放量；3）聚焦主业，持续推动资源整合。（每日经济新闻）
Guojin Securities released a research report on April 22 stating that it gave Kangenbei (600572.SH) an increase in its holdings. The main reasons for the rating include: 1) product structure optimization, healthy growth in the core business of Traditional
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated